Provided by Tiger Trade Technology Pte. Ltd.

GlucoTrack, Inc.

0.3474
+0.00581.70%
Post-market: 0.3310-0.0164-4.72%19:53 EDT
Volume:697.60K
Turnover:241.53K
Market Cap:3.68M
PE:-0.05
High:0.3698
Open:0.3378
Low:0.3303
Close:0.3416
52wk High:14.14
52wk Low:0.2500
Shares:10.58M
Float Shares:10.52M
Volume Ratio:0.13
T/O Rate:6.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.5183
EPS(LYR):-31.2159
ROE:-620.63%
ROA:-164.45%
PB:-2.11
PE(LYR):-0.01

Loading ...

LŌKahi Therapeutics™ Advances Lt-100 Development Strategy Toward Single-Injection Administration

THOMSON REUTERS
·
Jul 30

GlucoTrack Enters Exchange Deal on $900,000 Promissory Note with Investor

Reuters
·
Jul 28

E.f. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing

THOMSON REUTERS
·
Jul 18

Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.f. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives

THOMSON REUTERS
·
Jul 17

GlucoTrack (GCTK) Stock Rallies 16% After Hours: Here's What Is Going On

Benzinga
·
Jul 17

Update – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-controlled Public Platform

THOMSON REUTERS
·
Jul 17

Press Release: Update

Dow Jones
·
Jul 17

Glucotrack - Lokahi Therapeutics Becomes Wholly Owned Subsidiary of Glucotrack - SEC Filing

THOMSON REUTERS
·
Jul 16

Glucotrack - Lokahi Shareholders to Receive 19.99% of Glucotrack Common Stock Outstanding as of Merger Date - SEC Filing

THOMSON REUTERS
·
Jul 16

Glucotrack - Enters Merger Agreement with Lokahi Therapeutics on July 14, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 16

Top Premarket Gainers

MT Newswires Live
·
Jul 15

GlucoTrack, Lokahi Therapeutics Complete Merger

MT Newswires Live
·
Jul 15

YSX Tech Stock Soars 14% After Hours: Here's Why

Benzinga Earnings
·
Jul 15

Glucotrack (GCTK) Stock Is Trending Overnight — Here’s Why it Spiked Over 69% in After-Hours Session

Benzinga_recent_news
·
Jul 15

Glucotrack Names Erik Emerson CEO, Paul Goode CTO in Lōkahi Deal

Reuters
·
Jul 15

Press Release: Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-controlled Public Platform

Dow Jones
·
Jul 15

GlucoTrack announces USPTO notice of allowance for patent application

TIPRANKS
·
Jul 08

Glucotrack Says USPTO Allows Patent Claims for Implantable Continuous Blood Glucose Monitoring Platform

Reuters
·
Jul 08

Glucotrack Announces Uspto Notice of Allowance for Patent Application Covering Its Implantable Cbgm Platform

THOMSON REUTERS
·
Jul 08

GlucoTrack announces 2026 annual shareholder meeting

Reuters
·
Jun 18